WMT

109.21

+2.14%↑

COST

908.2

+1.59%↑

PG

148.35

-0.04%↓

KO

73.02

+0.62%↑

PM

156.68

-0.59%↓

WMT

109.21

+2.14%↑

COST

908.2

+1.59%↑

PG

148.35

-0.04%↓

KO

73.02

+0.62%↑

PM

156.68

-0.59%↓

WMT

109.21

+2.14%↑

COST

908.2

+1.59%↑

PG

148.35

-0.04%↓

KO

73.02

+0.62%↑

PM

156.68

-0.59%↓

WMT

109.21

+2.14%↑

COST

908.2

+1.59%↑

PG

148.35

-0.04%↓

KO

73.02

+0.62%↑

PM

156.68

-0.59%↓

WMT

109.21

+2.14%↑

COST

908.2

+1.59%↑

PG

148.35

-0.04%↓

KO

73.02

+0.62%↑

PM

156.68

-0.59%↓

Search

USANA Health Sciences Inc

Закрыт

20.03 1.47

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

19.97

Макс.

20.26

Ключевые показатели

By Trading Economics

Доход

-17M

-6.7M

Продажи

-22M

214M

P/E

Средняя по отрасли

21.733

27.583

Прибыль на акцию

-0.15

Рентабельность продаж

-3.118

Сотрудники

1,700

EBITDA

-17M

11M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+94.71% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-24M

358M

Предыдущая цена открытия

18.56

Предыдущая цена закрытия

20.03

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

27 нояб. 2025 г., 16:49 UTC

Приобретения, слияния, поглощения

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27 нояб. 2025 г., 15:32 UTC

Приобретения, слияния, поглощения

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27 нояб. 2025 г., 23:50 UTC

Обсуждения рынка

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27 нояб. 2025 г., 23:50 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

27 нояб. 2025 г., 16:05 UTC

Обсуждения рынка

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27 нояб. 2025 г., 16:04 UTC

Обсуждения рынка

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27 нояб. 2025 г., 15:54 UTC

Приобретения, слияния, поглощения

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27 нояб. 2025 г., 15:44 UTC

Приобретения, слияния, поглощения

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27 нояб. 2025 г., 15:43 UTC

Приобретения, слияния, поглощения

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27 нояб. 2025 г., 15:42 UTC

Приобретения, слияния, поглощения

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27 нояб. 2025 г., 15:41 UTC

Приобретения, слияния, поглощения

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27 нояб. 2025 г., 15:11 UTC

Обсуждения рынка

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27 нояб. 2025 г., 14:26 UTC

Обсуждения рынка

Hermes' Outperformance Gap Could Narrow -- Market Talk

27 нояб. 2025 г., 14:11 UTC

Обсуждения рынка

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27 нояб. 2025 г., 14:11 UTC

Обсуждения рынка

Market Talk Roundup: Latest on U.S. Politics

27 нояб. 2025 г., 13:35 UTC

Обсуждения рынка

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27 нояб. 2025 г., 13:33 UTC

Обсуждения рынка

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27 нояб. 2025 г., 13:22 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

27 нояб. 2025 г., 13:22 UTC

Обсуждения рынка

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27 нояб. 2025 г., 13:17 UTC

Обсуждения рынка

LVMH Should Be Able to Recover Next Year -- Market Talk

27 нояб. 2025 г., 11:13 UTC

Обсуждения рынка

European Gas Prices Come Under Pressure -- Market Talk

27 нояб. 2025 г., 11:07 UTC

Отчет

Genting: Positive About Prospects Over Longer Term

27 нояб. 2025 г., 11:06 UTC

Отчет

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27 нояб. 2025 г., 11:04 UTC

Отчет

Genting: International Travel Demand Expected to Remain Resilient

27 нояб. 2025 г., 11:04 UTC

Отчет

Genting: Global Growth Expected to Remain Subdued

27 нояб. 2025 г., 11:04 UTC

Отчет

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27 нояб. 2025 г., 10:59 UTC

Отчет

Genting Bhd 3Q Net Profit Fell 86% on Year

27 нояб. 2025 г., 10:58 UTC

Отчет

Genting Bhd 3Q Rev Rose 14% on Year

27 нояб. 2025 г., 10:56 UTC

Отчет

Genting Bhd 3Q Net MYR30.3M

27 нояб. 2025 г., 10:56 UTC

Отчет

Genting Bhd 3Q EPS MYR0.0079

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Целевая цена

By TipRanks

94.71% рост

Прогноз на 12 месяцев

Средняя 39 USD  94.71%

Максимум 39 USD

Минимум 39 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для USANA Health Sciences Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

1 ratings

0

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat